BALAXI — Balaxi Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapMomentum Trap

Annual balance sheet for Balaxi Pharmaceuticals, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2019 March 31st	2020 March 31st	2021 March 31st	2022 March 31st	2023 March 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IAS	IAS	IAS	IAS	IAS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	1.33	40	16.7	71.9	282
Net Total Accounts Receivable
Net Total Receivables	56.4	299	774	312	562
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	57.8	349	938	1,410	1,935
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.113	1.86	11.7	60.3	190
Net Goodwill
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	61.1	360	997	1,765	2,397
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	25.9	82.2	347	633	531
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	25.9	82.3	347	633	568
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	35.2	277	650	1,132	1,829
Total Liabilities & Shareholders' Equity	61.1	360	997	1,765	2,397
Total Common Shares Outstanding